Abstract: Dental dressing assemblies are formed from hydrophilic polymer sponge structures, such as a densified chitosan biomaterial. The invention also contemplates systems and methods that can be used in conjunction with stents and periodontal dressings to promote hemostasis and secondary healing in free gingival graft palatal donor sites and all other oral and maxillofacial surgical sites.

Abstract: Dental dressing assemblies are formed from hydrophilic polymer sponge structures, such as a densified chitosan biomaterial. The invention also contemplates systems and methods that can be used in conjunction with stents and periodontal dressings to promote hemostasis and secondary healing in free gingival graft palatal donor sites and all other oral and maxillofacial surgical sites.

Abstract: Dental dressing assemblies are formed from hydrophilic polymer sponge structures, such as a densified chitosan biomaterial.

Abstract: An improved biostable polyurethane-urea elastomeric composition derived from a silicon-containing diamine of formula (I).

Abstract: The present invention relates to a material having improved mechanical properties, clarity, processability and/or degradation resistance comprising a polyurethane elastomeric composition which includes a soft segment derived from at least one polysiloxane macrodiol and at least one polyether and/or polycarbonate macrodiol. This material can function as a degradation-resistant material or biomaterial and is particularly useful in the manufacture of medical devices, articles or implants which contact living tissue or bodily fluids. The present invention also provides a polyurethane elastomeric composition which includes a soft segment derived from at least one polysiloxane and at least one polyether and/or polycarbonate macrodiol and processes for its preparation.

Abstract: The present invention relates to a material having improved mechanical properties, clarity, processability and/or degradation resistance comprising a polyurethane elastomeric composition which includes a soft segment derived from at least one polysiloxane macrodiol and at least one polyether and/or polycarbonate macrodiol. This material can function as a degradation resistant material or biomaterial and is particularly useful in the manufacture of medical devices, articles or implants which contact living tissues or bodily fluids. The present invention also provides a polyurethane elastomeric composition which includes a soft segment derived from about 60 to about 98 wt. % of at least one polysiloxane macrodiol and about 2 to about 40 wt. % of at least one polyether and/or polycarbonate macrodiol and processes for its preparation.

Abstract: A non-elastomeric polyurethane composition which includes a first chain extender of the general formula (I) wherein R1, R2, R3, R4, R5, and R6 are the same or different and selected from an optionally substituted straight chain, branched or cyclic, saturated or unsaturated hydrocarbon radical; R7 is a divalent linking group or an optionally substituted straight chain, branched or cyclic, saturated or unsaturated hydrocarbon radical; and n is 0 or greater, and a second chain extender.

Abstract: A process for the purification of polyethers prepared by acid catalyzed condensation of polyhydroxy compounds includes the steps of: (a) heating the polyether with water for a time and at temperature sufficient to substantially hydrolyze esters formed during polymerization; and (b) separating the polyether from the water. The heating of the polyether and water may be conducted under reflux at a temperature of 60 to 100° C. for a period of 2 to 20 hours. The polyether recovered from step (b) may be subjected to further washing with hot water to remove residual acid.

Abstract: An improved biostable polyurethane-urea elastomeric composition derived from a silicon-containing diamine of formula (I).

Abstract: The present invention relates to a material having improved mechanical properties, clarity, processability and/or degradation resistance comprising a polyurethane elastomeric composition which includes a soft segment derived from at least one polysiloxane macrodiol and at least one polyether and/or polycarbonate macrodiol. This material can function as a degradation resistant material or biomaterial and is particularly useful in the manufacture of medical devices, articles or implants which contact living tissues or bodily fluids. The present invention also provides a polyurethane elastomeric composition which includes a soft segment derived from about 60 to 98 wt % of at least one polysiloxane macrodiol and about 2 to 40 wt % of at least one polyether and/or polycarbonate macrodiol and processes for its preparation.